Rapid growth in any business certainly attracts positive attention and in the world of clinical research trial sites even more so as scale becomes ever…
Private equity-backed site organization roll-up Velocity Clinical Research purchased eStudySite, contributing two trial site locations in San Diego, California to its North American site portfolio,…
Blackstone has raised more all purpose investment funds than another other private equity group in the United States. With the closing of Blackstone Life Sciences…
A new private equity health care fund with an emphasis on life sciences evidences the healthy investor appetite for health and life science-related activities. Cowen…
Central institutional review board (IRB) consolidator Advarra has acquired another firm—this time a boutique IRB firm called IRBco. This purchase represents the ongoing march of…
Clinical research site expansion continues at a healthy rate as CenExel Clinical Research, Inc. (“CenExel”) acquires Research Centers of America (RCA), a Hollywood, Florida based clinical investigational…
Private equity giant Blackstone, the world’s third largest private equity investor, continues to move deeper into the life sciences vertical pairing with Ferring Pharmaceuticals to ink…
Private equity continues to become more intrigued by clinical trials. From investing in clinical investigational sites to services providers to disruptive technologies, funds are seeking…
In yet another private equity-backed consolidation move in the clinical research site market, private equity made a power move again, this time underwriting a new…
Medicxi Introduces the €400 Medicxi III fund, closed in just six weeks, and brings the total funds raised in the last three years to over…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
